Working… Menu

A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03467867
Recruitment Status : Recruiting
First Posted : March 16, 2018
Last Update Posted : July 31, 2019
Hackensack Meridian Health
Information provided by (Responsible Party):
Maryam S. Yazdy, MD, Georgetown University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 15, 2023
Estimated Study Completion Date : October 15, 2023